PEMETREXED | EAGLE PHARMS | ||
500MG/20ML (25MG/ML) | |||
Yes | Yes | ||
2036-Feb-19 | Expired | ||
None | None | ||
None | No | ||
PEMFEXY is a folate analog metabolic inhibitor indicated for: • in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous, non-small cell lung cancer (NSCLC). • as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. • as a single agent for the treatment of patients with recurrent, metastatic non-squamous NSCLC after prior chemotherapy. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
500MG/20ML (25MG/ML) | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com